These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36610558)

  • 1. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders.
    Chakraborty P; Dey A; Gopalakrishnan AV; Swati K; Ojha S; Prakash A; Kumar D; Ambasta RK; Jha NK; Jha SK; Dewanjee S
    Ageing Res Rev; 2023 Mar; 85():101838. PubMed ID: 36610558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders.
    Wang SJ; Yang TT
    Drug News Perspect; 2005 Nov; 18(9):561-6. PubMed ID: 16421629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.
    Reiner A; Levitz J
    Neuron; 2018 Jun; 98(6):1080-1098. PubMed ID: 29953871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases.
    McGrath T; Baskerville R; Rogero M; Castell L
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.
    Köles L; Kató E; Hanuska A; Zádori ZS; Al-Khrasani M; Zelles T; Rubini P; Illes P
    Purinergic Signal; 2016 Mar; 12(1):1-24. PubMed ID: 26542977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM; Marek GJ; Johnson BG; Schoepp DD
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
    Barker-Haliski M; White HS
    Cold Spring Harb Perspect Med; 2015 Jun; 5(8):a022863. PubMed ID: 26101204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamatergic signaling in the brain's white matter.
    Bakiri Y; Burzomato V; Frugier G; Hamilton NB; Káradóttir R; Attwell D
    Neuroscience; 2009 Jan; 158(1):266-74. PubMed ID: 18314276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate: the new frontier in pharmacotherapy for cocaine addiction.
    Uys JD; LaLumiere RT
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):482-91. PubMed ID: 19128205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of glutamatergic neurotransmission in the nervous system.
    Niciu MJ; Kelmendi B; Sanacora G
    Pharmacol Biochem Behav; 2012 Feb; 100(4):656-64. PubMed ID: 21889952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders.
    Nicosia N; Giovenzana M; Misztak P; Mingardi J; Musazzi L
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic drive of the dorsal raphe nucleus.
    Soiza-Reilly M; Commons KG
    J Chem Neuroanat; 2011 Jul; 41(4):247-55. PubMed ID: 21550397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.
    Goodwani S; Saternos H; Alasmari F; Sari Y
    Neurosci Biobehav Rev; 2017 Jun; 77():14-31. PubMed ID: 28242339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glutamate and Alzheimer's disease].
    Gazulla J; Cavero-Nagore M
    Rev Neurol; 2006 Apr 1-15; 42(7):427-32. PubMed ID: 16602060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate-glutamine cycling in Alzheimer's disease.
    Walton HS; Dodd PR
    Neurochem Int; 2007 Jun; 50(7-8):1052-66. PubMed ID: 17141374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission.
    Monfort P; Muñoz MD; ElAyadi A; Kosenko E; Felipo V
    Metab Brain Dis; 2002 Dec; 17(4):237-50. PubMed ID: 12602501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between glutamatergic and GABAergic neurotransmission alterations in cognitive and motor impairment in minimal hepatic encephalopathy.
    Llansola M; Montoliu C; Agusti A; Hernandez-Rabaza V; Cabrera-Pastor A; Gomez-Gimenez B; Malaguarnera M; Dadsetan S; Belghiti M; Garcia-Garcia R; Balzano T; Taoro L; Felipo V
    Neurochem Int; 2015 Sep; 88():15-9. PubMed ID: 25447766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture.
    Burguière A; De Bundel D; Valjent E; Roger J; Smolders I; Fagni L; Perroy J
    Neuropharmacology; 2013 Mar; 66():151-7. PubMed ID: 22465815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and glutamatergic transmission.
    Tamminga CA
    Crit Rev Neurobiol; 1998; 12(1-2):21-36. PubMed ID: 9444480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.